Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorMeyer Children's Hospital IRCCS

About this trial

According to the WHO report of 2021, approximately 10 million new cases were reported in 2020, of which 1 million occurred in the pediatric population. However, epidemiological data available on tuberculosis (TB) in pediatric age are extremely limited due to diagnostic challenges in this patient category. Furthermore, children are almost never included in national surveillance systems due to the lack of connections between individual pediatricians, pediatric hospitals, and national surveillance programs. It is therefore reasonable to assume that the disease may be significantly underestimated both in Italy and worldwide.

Eligibility criteria

Qualifiers

Pediatric patients (0-18 years old) at the time of the initial observation

Patients affected by active and latent TB, as defined by the criteria of the World Health Organization

Patients exposed to TB who are found to be non-infected at the end of the window period

Informed consent signed by parents/legal guardian or by the patient who has reached the legal age of consent, assent of the minor

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed